STAT+: Pharmalittle: Half-dozen big insurers won’t cover new Alzheimer’s drug; Medicaid could spend up to $2.2 billion on the Biogen drug
Good morning, everyone, and how are you today? The sun is trying to peek through…
Category: Biotech
.jpg)
Opinion: Listen: An OB-GYN on the maternal mortality crisis in the U.S.
Why do more women die in and after childbirth in the U.S. than in any…
STAT+: ‘’This is unprecedented’: Several private insurers won’t cover Biogen’s Alzheimer’s drug
At least half-a-dozen private health insurers in some of the nation’s largest states are balking…
Extending the reach of gene therapies means hurdling not just scientific barriers but prices, too
While Covid-19 struck a blow to a vast number of clinical trials around the world,…
Opinion: Vaxxed or axed: To protect patients, every health care worker must be vaccinated
Masks are off. Theaters and indoor dining are back. Life seems to be returning to…
My pregnancy made me fear for my career as a physician. It doesn’t have to be that way
I cried when I found out I was pregnant with my second child. While I…
The world will not exit Covid-19 pandemic without booster shots, vaccine developer says
The world will not get the Covid-19 pandemic under control without using booster shots for…
Biden to nominate Atul Gawande for global health position
President Biden will nominate noted surgeon and writer Atul Gawande for a global health position…
STAT+: Insulin makers and pharmacy benefit managers must face racketeering claims in a lawsuit
A federal judge dropped allegations that three drug makers engaged in antitrust practices by scheming…
STAT+: ‘Aduhelm left room’: Lilly CEO eyes competition with Biogen Alzheimer’s drug
Though a rival’s Alzheimer’s drug reached the market first, the CEO of Eli Lilly spoke…
STAT+: Biogen’s new Alzheimer’s drug could cost Medicaid up to $2.2 billion a year
A pricey new Alzheimer’s drug already mired in controversy could cost Medicaid anywhere from $720…
Biden to nominate West Virginia’s Rahul Gupta as drug czar
WASHINGTON — President Biden will nominate Rahul Gupta, a March of Dimes executive and former…
Rest stop telehealth, a data aggregator gets buy-in, & the EHR time drain
Truveta scores $95 million, adds hospital partners Truveta, a company formed to aggregate patient data…
STAT+: Pharmalittle: Medicare starts coverage review for Biogen Alzheimer’s drug; U.S. needs more data before deciding on Covid booster shot
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
Biden wants a drug pricing plan in 45 days. Who’s going to write it?
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Patient data company Truveta raises $95 million, secures new hospital partners
A company formed to aggregate and sell de-identified data on millions of American patients has…
STAT+: If everyone already knows about a new biotech startup, why does it ‘launch’?
Biotech companies often linger in a corporate version of Schrödinger’s box — of existence and…
Opinion: Managed care’s role in protecting women from childbirth-related complications
The coronavirus pandemic brought the importance of public health to the forefront of national attention….
‘The party is winding down’: States and insurers resurrect barriers to telehealth, putting strain on patients
Telemedicine is here to stay. But its free-for-all era may be coming to an end….
When and how will we know if we need Covid-19 booster shots?
There’s a lot we don’t yet know about the data behind Pfizer and BioNTech’s renewed…
STAT+: Medicare starts process that could limit access to Biogen’s new Alzheimer’s drug
WASHINGTON — Federal officials on Monday announced the agency will start a process that could…
Powerful House Democrats demand documents from Biogen about coordination with FDA on new Alzheimer’s drug
WASHINGTON — Two powerful House Democrats on Monday demanded documents from Biogen about the approval…
STAT+: Biden’s executive order would pause a Trump rule forbidding march-in rights to lower drug costs
In a little-noticed move, the Biden administration has hit the pause button on a rule…
J&J’s Covid-19 vaccine may trigger neurological condition in rare cases, FDA says
Johnson & Johnson’s Covid-19 vaccine may trigger a rare neurological condition in a small number…
STAT+: Dozens of generic makers and pharmacies won’t face lawsuits over Zantac and cancer risks
A federal court judge dismissed all claims against dozens of generic manufacturers and retailers in…
WHO director-general slams notion of Covid-19 vaccine booster doses given global health needs
The director-general of the World Health Organization on Monday issued a stinging rebuke to Pfizer…
WHO director-general slams notion of Covid-19 vaccine booster doses given global health needs
The director-general of the World Health Organization on Monday issued a stinging rebuke to Pfizer…
STAT+: Pharmalittle: U.S. officials and Pfizer to meet over Covid-19 booster shots; FDA full approval for vaccines may not be a game changer
Good morning, everyone, and nice to see you again after we took an extended break….
World Health Organization advisers urge global effort to regulate genome editing
On Monday, a World Health Organization advisory committee called on the world’s largest public health…
Landmark gene therapy trial points to a wider window to alter course of rare disease
The suspicion that something was wrong started when the 1-year-old girl’s parents noticed she had…
Opinion: The decline in Covid-19 preceded vaccines. But we need jabs to finish the job
As coronavirus infections decline in the U.S., it seems appropriate to celebrate the triumph of…
.jpg)
Experts warn full Covid-19 vaccine approval is no quick fix for hesitancy
WASHINGTON — The Food and Drug Administration issuing full approval for two Covid-19 vaccines might…
STAT+: A Johns Hopkins startup aims to shake up AI in medicine with research-first approach
The formula for launching a machine learning company in health care looks something like this:…
Pfizer to discuss vaccine booster with U.S. officials Monday
WASHINGTON (AP) — Pfizer says it plans to meet with top U.S. health officials Monday…
FDA calls for federal investigation into its controversial Alzheimer’s drug approval
The head of the Food and Drug Administration has called for a wide-ranging federal investigation…
STAT+: Pharmalittle: Even FDA officials balked at the broad Aduhelm label; CDC and FDA are dubious about Covid booster shots
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
STAT+: In a sweeping executive order, Biden endorses importing drugs from Canada and orders a bigger drug pricing plan by late August
WASHINGTON — President Biden on Friday will take aim at the pharmaceutical industry by ordering…
Recent rulings may embolden hospital employees to speak publicly about safety issues
Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital…
STAT+: FDA extends shelf life for glaucoma drug discontinued by Pfizer, but patients remain concerned
In a bid to calm anxious patients, the Food and Drug Administration has extended the…
Opinion: With Aduhelm, is history repeating itself with another win for Wall Street and a loss for patients?
When I learned of the Food and Drug Administration’s approval of aducanumab (Aduhelm) for Alzheimer’s…
Opinion: Ignoring mental health infrastructure will be a costly mistake
President Biden’s ambitious infrastructure plan has a glaring omission: It makes no effort to redress…
Pfizer to seek FDA authorization for third, booster dose of its Covid-19 vaccine
Pfizer is about to seek U.S. authorization for a third dose of its Covid-19 vaccine,…
STAT+: House Democrats say pharma stock buybacks and dividends exceed R&D spending
A Congressional committee released a report on Thursday showing the 14 largest drug makers spent…
STAT+: FDA’s expansive Alzheimer’s drug approval surprised even top agency officials
WASHINGTON — The Food and Drug Administration’s contentious decision to approve a new Alzheimer’s drug…
Listen: Aduhelm’s latest twist, how Covid variants are shaping the summer, & a digital health boom
How worrying is the Delta variant? Is there a digital health bubble? And what is…
STAT+: Former Genentech scientist convicted of stealing trade secrets given to former JHL Biotech execs
A former Genentech principal scientist and her husband were convicted of stealing trade secrets and…
Gene hunters turn up new clues to help explain why Covid-19 hits some people so hard
On March 16, 2020, five days after the World Health Organization declared Covid-19 a global…
STAT+: Purdue reaches deal with 15 states in a significant step toward bankruptcy plan approval
Fifteen states have agreed to drop their long-standing objections to a contentious bankruptcy plan to…
STAT+: Pharmalittle: In rare move, FDA revises label for Biogen Alzheimer’s drug; former compounding exec gets added jail time
Good morning, everyone, and how are you today? The sun is trying to peek through…
STAT+: FDA, under fire from critics, revises prescribing information for Biogen’s Alzheimer’s drug
The Food and Drug Administration on Thursday changed the prescribing label for Biogen’s Alzheimer’s treatment…